Biomarin Pharmaceutical (BMRN)

Add to Watchlists
Create an Alert
60.89 -0.48  -0.78% NASDAQ Apr 17, 4:59PM BATS Real time Currency in USD
View Full Chart
BMRN Price Chart
View All Events

BMRN Events

Date Type Description
Mar 03 Misc Biomarin Pharmaceutical, Inc. Q4 2013 Earnings Conference Call
Mar 03 Earnings Biomarin Pharmaceutical, Inc. Q4 2013 Earnings Results. Estimate: -0.34.
Oct 24 Misc BioMarin to Host Third Quarter 2013 Financial Results Conference Call and Webcast
Oct 24 Earnings BioMarin -Third Quarter 2013 Financial Results. Estimate: -0.30.
Jul 25 Misc Second Quarter 2013 Financial Results Conference Call
Jul 25 Earnings BioMarin to Host Second Quarter 2013 Financial Results. Estimate: -0.28.
May 15 Misc AGM Event for Biomarin Pharmaceutical Inc.
Apr 25 Earnings Q1 Earnings Result. Estimate: -0.26.
Apr 25 Misc Q1 Earnings Call
View All Performance Charts

BMRN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Biomarin Pharmaceutical is down 5.83% over the last year vs S&P 500 Total Return up 20.96%, Alexion Pharmaceuticals up 55.82%, and Regeneron Pharmaceuticals up 37.25%.

Get Quote for

PDF Report for BMRN

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download BMRN Pro Report PDF

Portfolio Strategies Featuring BMRN

Did Biomarin Pharmaceutical make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

BMRN Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

BioMarin Pharmaceutical Inc. is a biotechnology firm based in Novato, California. It has offices and facilities in the US, South America, Asia and Europe. BioMarin's core business and research is in enzyme replacement therapies. BioMarin is the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin is also the first company to provide therapeutics for Phenylketonuria. The company sells its products to specialty pharmacies, hospitals acting as retailers, pharmaceutical wholesalers, and distributors in the United States, Europe, Latin America, and rest of the world. It has a collaboration agreement with Genzyme Corporation for the development of Aldurazyme; and an agreement with Merck Serono for the further development and commercialization of Kuvan and other products containing 6R-BH4 and PEG-PAL for PKU. BioMarin Pharmaceutical Inc. was founded in 1996.

Recent Quotes

Symbol Price Chg Chg % Market Cap
BMRN 60.89 -0.48 -0.78% 8.745B
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.